- Advertisement -
- The use of GLP-1 medications such as semaglutide — more widely known under the brand names of Ozempic and Wegovy — have greatly increased over the last few years.
- There has also been an increase in research examining other benefits these types of drugs might offer aside from type 2 diabetes management and weight loss.
- Recent results from a phase 3 clinical trial show that…
